G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2009
11/19/2009	US20090286231 Methods, Devices, Kits and Compositions for Detecting Roundworm, Whipworm, and Hookworm
11/19/2009	US20090286230 Methods, Devices, Kits and Compositions for Detecting Roundworm
11/19/2009	US20090286229 Methods, Devices, Kits and Compositions for Detecting Roundworm
11/19/2009	US20090286228 Methods, Devices, Kits and Compositions for Detecting Roundworm
11/19/2009	US20090286227 Methods, Devices, Kits and Compositions for Detecting Whipworm
11/19/2009	US20090286226 Simple membrane assay method and kit
11/19/2009	US20090286224 Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
11/19/2009	US20090286223 Methods And Kits For In Situ Measurement of Enzyme Activity and Amount Using Single Measurement System
11/19/2009	US20090285859 Allergenic proteins of natural rubber latex, their production and use in assays
11/19/2009	US20090285857 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
11/19/2009	US20090285847 Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis
11/19/2009	US20090285840 Methods for treating pathological neovascularization
11/19/2009	US20090285838 Use of soluble cd164 in inflammation and autoimmune disorders
11/19/2009	US20090285832 Methods for treating sunitinib-resistant carcinoma and related biomarkers
11/19/2009	US20090285827 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8 associated disorders
11/19/2009	US20090285823 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics
11/19/2009	US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009	US20090285821 Campylobacter Pilus Protein, Compositions and Methods
11/19/2009	US20090285820 Methods of Treating Degenerative Disorders With Rac 1B Inhibitor
11/19/2009	US20090285818 Cripto Blocking Antibodies and Uses Thereof
11/19/2009	US20090285812 human P-selectin glycoprotein ligand 1 (PSGL-1) monoclonal antibodies which block both selectin and chemokine binding to PSGL-1 expressed on leukocytes, lymphocytes and endothelial cells; inflammation such as inflammatory bowel disease
11/19/2009	US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009	US20090285807 Anti-Met Monoclonal Antibody, Fragments and Vectors Thereof, for the Treatment of Tumors and Corresponding Products
11/19/2009	US20090285801 Calcium-Sensing Receptor 2 (CaR2) and Methods for Using
11/19/2009	US20090285796 Mutant jak3 kinase in human leukemia
11/19/2009	US20090285757 Methods of targeting cells for diagnosis and therapy
11/19/2009	US20090285754 Peptides for targeting apoptotic cells and uses thereof
11/19/2009	US20090285751 Cancerous disease modifying antibodies
11/19/2009	US20090285750 Agent, composition and method
11/19/2009	US20090285719 Compressible Transparent Sealing for Open Microplates
11/19/2009	US20090284372 Glucose Measuring Device For Use In Personal Area Network
11/19/2009	US20090283524 Blood components separator disk
11/19/2009	US20090283426 Method for fabricating pattern on a biosensor substrate and biosensor using the same
11/19/2009	US20090283422 Stochastic Sensing Through Covalent Interactions
11/19/2009	US20090282908 Electrifiable fabric
11/19/2009	US20090282896 Connecting component for a breathing tube with a sensor for measuring the gas flow
11/19/2009	US20090282891 Method for Diagnosing the Reliability Performance of a Jump Probe
11/19/2009	DE202009004919U1 Struktur für einen Behälter für Teststreifen Structure for a container for test strips
11/19/2009	DE102009021315A1 Prognostisches Verfahren Prognostic methods
11/19/2009	DE102009020519A1 Verfahren zum Testen der Durchlässigkeit und Delaminierung von Materialien unter biaxialer Spannung und Scherkräften und Vorrrichtung zur Durchführung desselben Of the same method for testing the permeability and delamination of materials under biaxial stress and shear forces, and for carrying out Vorrrichtung
11/19/2009	DE102008024106A1 Vorrichtung zum Abscheiden von Partikeln in und aus Flüssigkeiten und deren Anwendung in Biotechnologie, biologische Forschung, Diagnostik und Krankheitsbehandlung Apparatus for separating particles in and out of liquids and their application in biotechnology, biological research, diagnosis and treatment of disease
11/19/2009	DE102008023545A1 Vorrichtung zur Herstellung einer biologisch aktiven Substanz An apparatus for producing a biologically active substance
11/19/2009	DE102008022609A1 Verfahren zum Nachweis von Erkrankungen der ableitenden Harnwege A method for the detection of disorders of the urinary tract
11/19/2009	DE102008022189A1 Measuring method for detecting aspirin resistance in blood of healthy and sick people, which before the measurement acetylsalicylic acid is need not to be taken
11/19/2009	DE102008001792A1 Inclination determining method for formation of whiskers in pure tin layer of electronic component, involves determining surface occupation by connections, and judging inclination for formation of whiskers from surface occupation
11/19/2009	CA2761571A1 Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
11/19/2009	CA2724583A1 High throughput methods of identifying neutral lipid synthases
11/19/2009	CA2724475A1 Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes
11/19/2009	CA2724433A1 Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
11/19/2009	CA2724415A1 Anti-psgl-1 antibodies and methods of identification and use
11/19/2009	CA2724332A1 Method of treatment
11/19/2009	CA2724312A1 Biomarkers for the identification, monitoring, and treatment of head and neck cancer
11/19/2009	CA2724243A1 Device and method for separating and analyzing blood
11/19/2009	CA2724220A1 Microanalysis chip adhesive sheet, microanalysis chip, and manufacturing method thereof
11/19/2009	CA2724170A1 Materials and methods relating to a g-protein coupled receptor
11/19/2009	CA2723852A1 Methods for the identification of parp interacting molecules and for the purification of parp proteins
11/19/2009	CA2723816A1 Chimeric small molecules for the recruitment of antibodies to cancer cells
11/19/2009	CA2723726A1 Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences
11/19/2009	CA2722996A1 Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue
11/19/2009	CA2722968A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3
11/19/2009	CA2722420A1 Methods for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin d synthase
11/19/2009	CA2722411A1 Treatment prediction involving hmgcr protein
11/19/2009	CA2721936A1 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
11/19/2009	CA2720124A1 Analysis of antibody drug conjugates by bead-based affinity capture and mass spectrometry
11/18/2009	EP2120051A1 Means and methods for predicting renal failure in diabetes patients based on placental growth factor and soluble FLT1
11/18/2009	EP2120050A1 Identification of ligand recognition domains
11/18/2009	EP2120049A1 Soluble thrombomodulin as a biomarker for treatments using anticoagulants
11/18/2009	EP2120048A1 Immune chromatographic strip disc for multiple analysis and detecting method by using it
11/18/2009	EP2120047A1 Method for detecting physico-chemical properties of a petroleum sample starting from two-dimensional gas chromatography
11/18/2009	EP2120041A2 Analysis of a mixture of biological and/or chemical components using magnetic particles
11/18/2009	EP2120038A2 Microtube reader device for the analysis of blood samples
11/18/2009	EP2119797A1 Method of detecting amplification or deletion in genomic dna fragment
11/18/2009	EP2119795A1 Biosensor electrode
11/18/2009	EP2119785A1 Novel peptides
11/18/2009	EP2119778A1 Method for activation of helper t cell and composition for use in the method
11/18/2009	EP2119777A1 Gaba neuron progenitor cell marker 65b13
11/18/2009	EP2119772A1 METHOD FOR PRODUCTION OF TRACP5b
11/18/2009	EP2119769A1 Method for production of hair and biomaterial
11/18/2009	EP2119728A1 Therapeutic and diagnostic agents
11/18/2009	EP2119726A1 Novel and powerful MHC-class II peptides derived from survivin and neurocan
11/18/2009	EP2119722A1 Labelled nucleotides
11/18/2009	EP2119706A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
11/18/2009	EP2119453A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of b-chronic lymphocytic leukaemia
11/18/2009	EP2119448A1 High affinity binding site of HGFR and methods for identification of antagonists thereof
11/18/2009	EP2118772A2 Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
11/18/2009	EP2118668A1 Method of determining nt-probnp
11/18/2009	EP2118667A2 Method and markers for the diagnosis of renal diseases
11/18/2009	EP2118666A1 Method for the standardization of the concentration of analytes in a urine sample
11/18/2009	EP2118665A1 Diagnosis of septic complications
11/18/2009	EP2118664A1 Peptide markers for diagnosis of preeclampsia
11/18/2009	EP2118662A1 Peptide markers for diagnosis of angiogenesis
11/18/2009	EP2118661A1 Method and device for the determination of minor cell populations in heterogeneous cell populations
11/18/2009	EP2118660A1 Sorting of microdevices
11/18/2009	EP2118659A1 Analyte manipulation and detection
11/18/2009	EP2118658A2 Improved homogeneous luminescence bioassay
11/18/2009	EP2118657A2 Non-denaturing lysis reagent for use with capture-in-solution immunoassay
11/18/2009	EP2118655A2 Non-denaturing lysis reagent
11/18/2009	EP2118654A2 Diagnostic test for the detection of a molecule or drug in whole blood
11/18/2009	EP2118653A2 Materials and methods for efficient and accurate detection of analytes
11/18/2009	EP2118652A1 Serum proteomics system and associated methods

1 ... 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 ... 3937